Prevalence, incidence and associated factors for HBV infection among male and female prisoners in Central Brazil: A multicenter study.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 27 02 2020
revised: 06 04 2020
accepted: 08 04 2020
pubmed: 22 4 2020
medline: 24 9 2020
entrez: 22 4 2020
Statut: ppublish

Résumé

Prison populations are at high risk for hepatitis B virus (HBV) infection. The aim of this study was to assess the prevalence, incidence, HBV associated factors and circulating genotypes/subtypes. A total of 3,368 prisoners from 12 closed prisons were randomly recruited for a cross-sectional study. In addition, a cohort study was conducted 12 months later and included 1,656 individuals. Participants underwent an interview and blood collection for the detection of HBV serological markers and HBV-DNA phylogenetic analysis. HBV exposure (anti-HBc+) was 9.8% (95% CI: 8.8-10.8); 11.2% were female and 9.6% were male. HBsAg+ was 0.6%. Only 31.4% of the participants had HBV vaccination-like profile (anti-HBs+ alone; 30.4% male vs. 36.8% female; p=0.004). Most individuals were susceptible to HBV (60.2% female vs. 52.2% male, p=0.001). HBV isolates were classified as genotypes A (45.4%), D (27.3%) and F (27.3%). In males, HBV exposure was associated with increased age. Male prisoners had more evidence of HCV/HBV co-infection (10.7%) than females (3.4%) and the frequency of Treponema pallidum infection among prisoners who had been exposed to HBV was higher in female prisoners when compared with male (39.7% vs. 19.1%). The incidence of HBV was 0.18/100 person-years (95% CI: 0.12%-0.25%). Our results indicate a high prevalence of HBV exposure in prisoners. Despite the low incidence of this infection, the occurrence of new cases indicates the need to implement preventive measures.

Sections du résumé

BACKGROUND BACKGROUND
Prison populations are at high risk for hepatitis B virus (HBV) infection. The aim of this study was to assess the prevalence, incidence, HBV associated factors and circulating genotypes/subtypes.
METHODS METHODS
A total of 3,368 prisoners from 12 closed prisons were randomly recruited for a cross-sectional study. In addition, a cohort study was conducted 12 months later and included 1,656 individuals. Participants underwent an interview and blood collection for the detection of HBV serological markers and HBV-DNA phylogenetic analysis.
RESULTS RESULTS
HBV exposure (anti-HBc+) was 9.8% (95% CI: 8.8-10.8); 11.2% were female and 9.6% were male. HBsAg+ was 0.6%. Only 31.4% of the participants had HBV vaccination-like profile (anti-HBs+ alone; 30.4% male vs. 36.8% female; p=0.004). Most individuals were susceptible to HBV (60.2% female vs. 52.2% male, p=0.001). HBV isolates were classified as genotypes A (45.4%), D (27.3%) and F (27.3%). In males, HBV exposure was associated with increased age. Male prisoners had more evidence of HCV/HBV co-infection (10.7%) than females (3.4%) and the frequency of Treponema pallidum infection among prisoners who had been exposed to HBV was higher in female prisoners when compared with male (39.7% vs. 19.1%). The incidence of HBV was 0.18/100 person-years (95% CI: 0.12%-0.25%).
CONCLUSIONS CONCLUSIONS
Our results indicate a high prevalence of HBV exposure in prisoners. Despite the low incidence of this infection, the occurrence of new cases indicates the need to implement preventive measures.

Identifiants

pubmed: 32315810
pii: S1201-9712(20)30240-X
doi: 10.1016/j.ijid.2020.04.019
pii:
doi:

Substances chimiques

Hepatitis B Antibodies 0
Hepatitis B Surface Antigens 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-307

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

G R Rezende (GR)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

B V Lago (BV)

Fiocruz, Oswaldo Cruz Institute, Rio de Janeiro, RJ, Brazil; Immunobiological Technology Institute, Fiocruz, RJ, Brazil. Electronic address: barbaravlago@gmail.com.

M A Puga (MA)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

L M Bandeira (LM)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

M A Pompilio (MA)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

Vol Castro (V)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

T S Tanaka (TS)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

G A Cesar (GA)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

Smvl Oliveira (S)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

Rts Yassuda (R)

Division of Health, State Agency of the Administration of Prisons, MS, Brazil.

S Simionatto (S)

Federal University of Grande Dourados, Dourados, MS, Brazil.

Sms Weis (S)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.

S F Basílio (SF)

Division of Health, State Agency of the Administration of Prisons, MS, Brazil.

J Croda (J)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil; Fiocruz Mato Grosso do Sul, Oswaldo Cruz Foundation, Brazil.

Arc Motta-Castro (A)

Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil; Fiocruz Mato Grosso do Sul, Oswaldo Cruz Foundation, Brazil. Electronic address: arcm.castro@hotmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH